Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.
Are you a US-based MD who sees patients with neurologic disorders and who likes to write? Why not blog for NeurologyTimes.com? It's your place to be heard on topics that keep you up at night. Contact us here and we can send you the details.